IMMUNE-MEDIATED ENCEPHALOPATHY

This adverse event was reported 89 times

These drugs are most commonly taken by patients reporting IMMUNE-MEDIATED ENCEPHALOPATHY:

# Drug Count
0 NIVOLUMAB 43
1 IPILIMUMAB 18
2 CARBOPLATIN 8
3 CABOZANTINIB 5
4 DURVALUMAB 4
5 ETOPOSIDE 3
6 AMLODIPINE BESYLATE 2
7 AXICABTAGENE CILOLEUCEL 2
8 BISOPROLOL FUMARATE 2
9 BLINATUMOMAB 2
See all common drugs associated with IMMUNE-MEDIATED ENCEPHALOPATHY

IMMUNE-MEDIATED ENCEPHALOPATHY is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 BEVACIZUMAB-BVZR 1 0.0014
1 ESTAZOLAM 1 0.0005
2 BREXUCABTAGENE AUTOLEUCEL 1 0.0005
3 TREMELIMUMAB 2 0.0005
4 NIVOLUMAB 43 0.0004
5 IPILIMUMAB 18 0.0004
6 GLYCERIN SUPPOSITORY 1 0.0004
7 GLYCERIN SUPPOSITORIES 1 0.0004
8 SITAGLIPTIN PHOSPHATE 1 0.0004
9 LEMBOREXANT 1 0.0003
See all drugs enriched for association with IMMUNE-MEDIATED ENCEPHALOPATHY